A real-world study to determine clinical benefits of Venetoclax treatment regimen in relapsed refractory multiple myeloma patients without t(11;14)
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary) ; Venetoclax (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association